This Government Contract opportunity from Department Of Defense was posted on May 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Manufacturing and Formulation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the manufacture and formulation of Fluticasone Propionate Inhalation Aerosol, specifically the 220 mcg dosage in 12g containers with 120 metered doses per unit. Production must comply with FDA current good manufacturing practices (cGMP) as well as meet military specifications, ensuring quality and regulatory standards are strictly maintained. This subcontract is managed by the Department of Defense under the Medical Supply Chain Pharmaceutical FSA, indicating a focus on supplying healthcare products for military use. The manufacturing site is located in FPO with the ZIP code 96607, aligning the performance of the contract with military logistics locations. The solicitation was posted on May 31, 2026, with a response deadline of June 8, 2026, reflecting a concise timeframe for interested parties to submit proposals. The contract falls under NAICS code 325412, which covers pharmaceutical preparation manufacturing, emphasizing the technical and specialized nature of this production requirement.
General Info
Agency
NAICS
Place of Performance
FPO, AP, 96607, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
